{"id":3808,"date":"2020-08-26T09:16:52","date_gmt":"2020-08-26T09:16:52","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/rapid-diagnostics-from-whole-blood-for-bacterial-and-fungal-pathogens\/"},"modified":"2021-01-08T11:20:53","modified_gmt":"2021-01-08T11:20:53","slug":"rapid-diagnostics-from-whole-blood-for-bacterial-and-fungal-pathogens","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/rapid-diagnostics-from-whole-blood-for-bacterial-and-fungal-pathogens\/","title":{"rendered":"Rapid diagnostics from whole blood for bacterial and fungal pathogens"},"content":{"rendered":"
T2 Biosystems\u2019 T2Bacteria\u00ae<\/sup> and T2Candida\u00ae<\/sup> Panels are the first and only FDA-cleared and CE-marked tests that identify the most serious bacterial and fungal pathogens directly from blood sample in just three to five hours, without waiting for a positive blood culture \u2014which can take one to six or more days. These capabilities allow for faster species identification, enabling the potential for faster targeted treatment, de-escalation of empiric therapy and improved patient outcomes.
All T2Direct DiagnosticsTM panels are run on the T2Dx\u00ae<\/sup> Instrument using a patient\u2019s blood sample with validated clinical sensitivity of 91 to 96% and specificity of 98 to 99%. The direct from blood capability is enabled by the proprietary T2MR-powered T2Dx\u00ae<\/sup> Instrument which can detect organisms at concentrations as low as 1 CFU\/mL. This represents a thousandfold increase in sensitivity compared to products that detect species from positive blood culture bottles where the number of cells is typically in the range of 10,000 to 10,000,000 CFUs\/mL.
T2 Biosystems recently received FDA Breakthrough Designation for the T2ResistanceTM Panel, a diagnostic panel that can detect 13 resistance genes from both gram-positive and gram-negative pathogens from a single patient blood sample in 3 to 5 hours. The T2Resistance Panel is also run on the T2Dx instrument and is expected to be CE-marked and available in Europe by the end of 2019, and offered as a Research Use Only product in the United States before yearend.
\nT2 Biosystems will showcase its latest innovations at ECCMID at Booth #1.22. <\/p>\n
\nSupplier:<\/strong> T2 Biosystems
\nWebsite:<\/strong> <\/a><\/p>\n